|
RP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.908970E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.890200E-01 |
| Normal-vs-Stage2 |
2.542800E-01 |
| Normal-vs-Stage3 |
5.779700E-02 |
| Normal-vs-Stage4 |
9.373400E-01 |
| Stage1-vs-Stage2 |
3.306600E-01 |
| Stage1-vs-Stage3 |
6.160200E-02 |
| Stage1-vs-Stage4 |
9.498800E-01 |
| Stage2-vs-Stage3 |
3.702600E-01 |
| Stage2-vs-Stage4 |
5.121000E-01 |
| Stage3-vs-Stage4 |
2.691800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.708600E-01 |
| Normal-vs-AfricanAmerican |
2.098000E-01 |
| Normal-vs-Asian |
2.521400E-01 |
| Caucasian-vs-AfricanAmerican |
3.010000E-01 |
| Caucasian-vs-Asian |
3.346200E-01 |
| AfricanAmerican-vs-Asian |
6.354600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.972200E-01 |
| Normal-vs-Female |
4.256600E-03 |
| Male-vs-Female |
3.079600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.698000E-01 |
| Normal-vs-Extreme_Weight |
4.751800E-01 |
| Normal-vs-Obese |
2.060800E-01 |
| Normal-vs-Extreme_Obese |
5.895200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.863800E-01 |
| Normal_Weight-vs-Obese |
5.895400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.215400E-01 |
| Extreme_Weight-vs-Obese |
8.377800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.147800E-01 |
| Obese-vs-Extreme_Obese |
3.268000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.497000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.369850E-02 |
| Normal-vs-Age(61-80Yrs) |
5.268800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.386600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.013200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.707600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.016400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.002300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.707000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.738000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.112200E-01 |
| Normal-VS-Type2 PRCC |
2.371800E-01 |
| Normal-VS-KIRP CIMP |
4.880600E-01 |
| Normal-VS-Unclassified PRCC |
2.390200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.552000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.689000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.556100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.281800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.980800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.094600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.359000E-01 |
| Normal-vs-N1 |
9.046100E-02 |
| Normal-vs-N2 |
2.010800E-01 |
| N0-vs-N1 |
1.264420E-01 |
| N0-vs-N2 |
4.696200E-01 |
| N1-vs-N2 |
2.626400E-01 |
|
|
